Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|May 10, 2007
The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acidGerda Rudolph, Petra Kloeters-Plachky, Daniel Rost, et al.
Hepatology (Baltimore, Md.)|September 7, 2004
Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitisDaniel Rost, Gerda Rudolph, Petra Kloeters-Plachky, et al.
Journal of Hepatology|May 18, 2010
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survivalGerda Rudolph, Daniel Gotthardt, Petra Kloeters-Plachky, et al.
Journal of Hepatology|September 19, 2006
Biliary candida infections in primary sclerosing cholangitisHasan Kulaksiz, Gerda Rudolph, Petra Kloeters-Plachky, et al.
World Journal of Gastroenterology|September 10, 2019
Ustekinumab: "Real-world" outcomes and potential predictors of nonresponse in treatment-refractory Crohn's diseasePeter Hoffmann, Johannes Krisam, Cyrill Wehling, et al.
Medicine|April 29, 2016
Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing CholangitisAnnika Gauss, Peter Sauer, Adolf Stiehl, et al.
World Journal of Gastroenterology|September 12, 2013
Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitisAnnika Gauss, Robert Ehehalt, Wolf-Dieter Lehmann, et al.
Plos One|January 19, 2012
S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitisLisa Reinhard, Christian Rupp, Hans-Dieter Riedel, et al.
Pageof 1